Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

How do children with and without ADHD talk about frustration?: Use of a novel emotion narrative recall task.

Fogleman ND, Leaberry KD, Rosen PJ, Walerius DM, Slaughter K.

Atten Defic Hyperact Disord. 2018 Mar 28. doi: 10.1007/s12402-018-0255-z. [Epub ahead of print]

PMID:
29594723
2.

Relation between internalizing behaviors, externalizing behaviors, and peer victimization among children with and without ADHD.

Fogleman ND, Leaberry KD, Rosen PJ, Walerius DM, Slaughter KE.

Atten Defic Hyperact Disord. 2018 Jan 12. doi: 10.1007/s12402-018-0248-y. [Epub ahead of print]

PMID:
29330700
3.

Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma.

Cohen A, Spektor TM, Stampleman L, Bessudo A, Rosen PJ, Klein LM, Woliver T, Flam M, Eshaghian S, Nassir Y, Maluso T, Swift RA, Vescio R, Berenson JR.

Br J Haematol. 2018 Jan;180(1):60-70. doi: 10.1111/bjh.14992. Epub 2017 Nov 21.

PMID:
29164606
4.

Intolerance of uncertainty in children with attention-deficit/hyperactivity disorder.

Gramszlo C, Fogleman ND, Rosen PJ, Woodruff-Borden J.

Atten Defic Hyperact Disord. 2017 Nov 9. doi: 10.1007/s12402-017-0244-7. [Epub ahead of print]

PMID:
29124553
5.

Comorbid Internalizing and Externalizing Disorders Predict Lability of Negative Emotions Among Children With ADHD.

Leaberry KD, Rosen PJ, Fogleman ND, Walerius DM, Slaughter KE.

J Atten Disord. 2017 Oct 1:1087054717734647. doi: 10.1177/1087054717734647. [Epub ahead of print]

PMID:
28992752
6.

The association of emotional lability and emotional and behavioral difficulties among children with and without ADHD.

Rosen PJ, Walerius DM, Fogleman ND, Factor PI.

Atten Defic Hyperact Disord. 2015 Dec;7(4):281-94. doi: 10.1007/s12402-015-0175-0. Epub 2015 May 10.

PMID:
25957599
7.

Functional Impairment Variability in Children With ADHD Due to Emotional Impulsivity.

Walerius DM, Reyes RA, Rosen PJ, Factor PI.

J Atten Disord. 2018 Jun;22(8):724-737. doi: 10.1177/1087054714561859. Epub 2014 Dec 17.

PMID:
25520165
8.

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.

Borad MJ, Reddy SG, Bahary N, Uronis HE, Sigal D, Cohn AL, Schelman WR, Stephenson J Jr, Chiorean EG, Rosen PJ, Ulrich B, Dragovich T, Del Prete SA, Rarick M, Eng C, Kroll S, Ryan DP.

J Clin Oncol. 2015 May 1;33(13):1475-81. doi: 10.1200/JCO.2014.55.7504. Epub 2014 Dec 15.

9.

Social Self Control, Externalizing Behavior, and Peer Liking Among Children with ADHD-CT: A Mediation Model.

Rosen PJ, Vaughn AJ, Epstein JN, Hoza B, Arnold LE, Hechtman L, Molina BS, Swanson JM.

Soc Dev. 2014 May 1;23(2):288-305.

10.

Examining the relationships between self-efficacy, task-relevant attentional control , and task performance: Evidence from event-related brain potentials.

Themanson JR, Rosen PJ.

Br J Psychol. 2015 May;106(2):253-71. doi: 10.1111/bjop.12091. Epub 2014 Sep 13.

PMID:
25220736
11.

The effects of social exclusion on the ERN and the cognitive control of action monitoring.

Themanson JR, Ball AB, Khatcherian SM, Rosen PJ.

Psychophysiology. 2014 Mar;51(3):215–25.

PMID:
25003166
12.

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.

Verstovsek S, Passamonti F, Rambaldi A, Barosi G, Rosen PJ, Rumi E, Gattoni E, Pieri L, Guglielmelli P, Elena C, He S, Contel N, Mookerjee B, Sandor V, Cazzola M, Kantarjian HM, Barbui T, Vannucchi AM.

Cancer. 2014 Feb 15;120(4):513-20.

13.

A phase I/II study of carfilzomib 2-10-min infusion in patients with advanced solid tumors.

Papadopoulos KP, Burris HA 3rd, Gordon M, Lee P, Sausville EA, Rosen PJ, Patnaik A, Cutler RE Jr, Wang Z, Lee S, Jones SF, Infante JR.

Cancer Chemother Pharmacol. 2013 Oct;72(4):861-8. doi: 10.1007/s00280-013-2267-x. Epub 2013 Aug 25.

14.

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.

Vacirca JL, Acs PI, Tabbara IA, Rosen PJ, Lee P, Lynam E.

Ann Hematol. 2014 Mar;93(3):403-9. doi: 10.1007/s00277-013-1879-x. Epub 2013 Aug 17.

15.

The Relation of Poor Emotional Awareness and Externalizing Behavior Among Children With ADHD.

Factor PI, Rosen PJ, Reyes RA.

J Atten Disord. 2016 Feb;20(2):168-77. doi: 10.1177/1087054713494005. Epub 2013 Jul 9.

PMID:
23839724
16.

I know it when I quantify it: ecological momentary assessment and recurrence quantification analysis of emotion dysregulation in children with ADHD.

Rosen PJ, Epstein JN, Van Orden G.

Atten Defic Hyperact Disord. 2013 Sep;5(3):283-94. doi: 10.1007/s12402-013-0101-2. Epub 2013 Jan 22.

17.

Emotional Impulsivity and Emotional and Behavioral Difficulties Among Children With ADHD: An Ecological Momentary Assessment Study.

Rosen PJ, Factor PI.

J Atten Disord. 2015 Sep;19(9):779-93. doi: 10.1177/1087054712463064. Epub 2012 Nov 19.

PMID:
23172248
18.

Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer.

Chi KN, Tolcher A, Lee P, Rosen PJ, Kollmannsberger CK, Papadopoulos KP, Patnaik A, Molina A, Jiao J, Pankras C, Kaiser B, Bernard A, Tran N, Acharya M.

Cancer Chemother Pharmacol. 2013 Jan;71(1):237-44. doi: 10.1007/s00280-012-2001-0. Epub 2012 Oct 12.

PMID:
23064959
19.

Alterations in error-related brain activity and post-error behavior over time.

Themanson JR, Rosen PJ, Pontifex MB, Hillman CH, McAuley E.

Brain Cogn. 2012 Nov;80(2):257-65. doi: 10.1016/j.bandc.2012.07.003. Epub 2012 Aug 30.

PMID:
22940400
20.

A phase I single-agent study of twice-weekly consecutive-day dosing of the proteasome inhibitor carfilzomib in patients with relapsed or refractory multiple myeloma or lymphoma.

Alsina M, Trudel S, Furman RR, Rosen PJ, O'Connor OA, Comenzo RL, Wong A, Kunkel LA, Molineaux CJ, Goy A.

Clin Cancer Res. 2012 Sep 1;18(17):4830-40. Epub 2012 Jul 3.

21.

Dysregulated negative emotional reactivity as a predictor of chronic peer victimization in childhood.

Rosen PJ, Milich R, Harris MJ.

Aggress Behav. 2012 Sep-Oct;38(5):414-27. doi: 10.1002/ab.21434. Epub 2012 Jun 15.

PMID:
22707083
22.

An event-related examination of neural activity during social interactions.

Themanson JR, Khatcherian SM, Ball AB, Rosen PJ.

Soc Cogn Affect Neurosci. 2013 Aug;8(6):727-33. doi: 10.1093/scan/nss058. Epub 2012 May 10.

23.

Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.

Scher HI, Jia X, Chi K, de Wit R, Berry WR, Albers P, Henick B, Waterhouse D, Ruether DJ, Rosen PJ, Meluch AA, Nordquist LT, Venner PM, Heidenreich A, Chu L, Heller G.

J Clin Oncol. 2011 Jun 1;29(16):2191-8. doi: 10.1200/JCO.2010.32.8815. Epub 2011 Apr 11.

PMID:
21483004
24.

Evidence for higher reaction time variability for children with ADHD on a range of cognitive tasks including reward and event rate manipulations.

Epstein JN, Langberg JM, Rosen PJ, Graham A, Narad ME, Antonini TN, Brinkman WB, Froehlich T, Simon JO, Altaye M.

Neuropsychology. 2011 Jul;25(4):427-441. doi: 10.1037/a0022155. Erratum in: Neuropsychology. 2013 Jan;27(1):106.

25.

A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung.

Leighl NB, Raez LE, Besse B, Rosen PJ, Barlesi F, Massarelli E, Gabrail N, Hart LL, Albain KS, Berkowitz L, Melnyk O, Shepherd FA, Sternas L, Ackerman J, Shun Z, Miller VA, Herbst RS.

J Thorac Oncol. 2010 Jul;5(7):1054-9.

26.

A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors.

Rosen PJ, Sweeney CJ, Park DJ, Beaupre DM, Deng H, Leitch IM, Shubhakar P, Zhu M, Oliner KS, Anderson A, Yee LK.

Clin Cancer Res. 2010 May 1;16(9):2677-87. doi: 10.1158/1078-0432.CCR-09-2862. Epub 2010 Apr 20.

27.

Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.

Gomes AS, Rosove MH, Rosen PJ, Amado RG, Sayre JW, Monteleone PA, Busuttil RW.

AJR Am J Roentgenol. 2009 Dec;193(6):1665-71. doi: 10.2214/AJR.08.1806.

PMID:
19933662
28.

Mental health as a mediator of gender differences in employment barriers among drug abusers.

Webster JM, Rosen PJ, McDonald HS, Staton-Tindall M, Garrity TF, Leukefeld CG.

Am J Drug Alcohol Abuse. 2007;33(2):259-65.

PMID:
17497549
29.

Gender, mental health, and treatment motivation in a drug court setting.

Webster JM, Rosen PJ, Krietemeyer J, Mateyoke-Scrivner A, Staton-Tindall M, Leukefeld C.

J Psychoactive Drugs. 2006 Dec;38(4):441-8.

PMID:
17373560
30.

Treatment motivation and therapeutic engagement in prison-based substance use treatment.

Rosen PJ, Hiller ML, Webster JM, Staton M, Leukefeld C.

J Psychoactive Drugs. 2004 Sep;36(3):387-96.

PMID:
15559685
31.

Testing psychodynamic psychotherapy skills among psychiatric residents: the psychodynamic psychotherapy competency test.

Mullen LS, Rieder RO, Glick RA, Luber B, Rosen PJ.

Am J Psychiatry. 2004 Sep;161(9):1658-64.

PMID:
15337657
32.
33.

A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.

Rosen PJ, Rankin C, Head DR, Boldt DH, Luthardt FW, Norwood T, Pugh RP, Karanes C, Appelbaum FR.

Leuk Res. 2000 Mar;24(3):183-7.

PMID:
10738999
34.

A phase II trial of irinotecan in hormone-refractory prostate cancer.

Reese DM, Tchekmedyian S, Chapman Y, Prager D, Rosen PJ.

Invest New Drugs. 1998-1999;16(4):353-9.

PMID:
10426671
35.

Oncogenic osteomalacia associated with prostate cancer.

Reese DM, Rosen PJ.

J Urol. 1997 Sep;158(3 Pt 1):887. No abstract available.

PMID:
9258108
36.

Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria.

Paquette RL, Yoshimura R, Veiseh C, Kunkel L, Gajewski J, Rosen PJ.

Br J Haematol. 1997 Jan;96(1):92-7.

PMID:
9012693
37.

Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy.

Rosen PJ, Mendoza EF, Landaw EM, Mondino B, Graves MC, McBride JH, Turcillo P, deKernion J, Belldegrun A.

J Clin Oncol. 1996 May;14(5):1626-36.

PMID:
8622081
38.

Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus.

Paquette RL, Meshkinpour A, Rosen PJ.

Medicine (Baltimore). 1994 May;73(3):145-52. Review.

PMID:
8190037
39.

Fentanyl for epidural intravascular test dose in obstetrics.

Yoshii WY, Miller M, Rottman RL, Kotelko DM, Wright WC, Stone JJ, Rasmus KT, Rosen PJ.

Reg Anesth. 1993 Sep-Oct;18(5):296-9. Erratum in: Reg Anesth 1994 May-Jun;19(3):precedi.

PMID:
8268118
40.

Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer.

Leichman CG, Leichman L, Spears CP, Rosen PJ, Jeffers S, Groshen S.

J Natl Cancer Inst. 1993 Jan 6;85(1):41-4.

PMID:
8416255
41.

Bleeding problems in the cancer patient.

Rosen PJ.

Hematol Oncol Clin North Am. 1992 Dec;6(6):1315-28. Review.

PMID:
1452514
42.

A phase II trial of CI-921 in advanced malignancies.

Sklarin NT, Wiernik PH, Grove WR, Benson L, Mittelman A, Maroun JA, Stewart JA, Robert F, Doroshow JH, Rosen PJ, et al.

Invest New Drugs. 1992 Nov;10(4):309-12.

PMID:
1487405
43.

Biological modification of protracted infusion of 5-fluorouracil with weekly leucovorin. A dose seeking clinical trial for patients with disseminated gastrointestinal cancers.

Leichman CG, Leichman L, Spears CP, Rosen PJ, Muggia F, Jeffers S, Waugh W.

Cancer Chemother Pharmacol. 1990;26(1):57-61.

PMID:
2182214
44.

Should we bother subclassifying Hodgkin's disease?

Rosen PJ.

J Clin Oncol. 1986 Mar;4(3):275-7. No abstract available.

PMID:
3950672
45.

Acute lymphocytic leukemia manifesting as splenic rupture.

Johnson CS, Rosen PJ, Sheehan WW.

Am J Clin Pathol. 1979 Jul;72(1):118-21.

PMID:
287370
46.

Tamoxifen flare in advanced breast cancer.

Plotkin D, Lechner JJ, Jung WE, Rosen PJ.

JAMA. 1978 Dec 8;240(24):2644-6.

PMID:
712982
47.

Convoluted lymphocytic lymphoma in adults: a clinicopathologic entity.

Rosen PJ, Feinstein DI, Pattengale PK, Tindle BH, Williams AH, Cain MJ, Bonorris JB, Parker JW, Lukes RJ.

Ann Intern Med. 1978 Sep;89(3):319-24.

PMID:
686542
48.

Cancer immunotherapy.

Plotkin D, Rosen PJ.

JAMA. 1976 Aug 30;236(9):1012-3. No abstract available.

PMID:
989573
49.

Study of leukocyte kinetics in acute myelocytic leukemia utilizing chromium-51.

Rosen PJ, Eyre HJ, Lilien DL, Perry S.

Med Pediatr Oncol. 1975;1(1):51-62.

PMID:
1066522
50.

Lymphocyte-depletion Hodgkin's disease. A clinicopathological entity.

Neiman RS, Rosen PJ, Lukes RJ.

N Engl J Med. 1973 Apr 12;288(15):751-5. No abstract available.

PMID:
4688713

Supplemental Content

Loading ...
Support Center